Mycotopia Therapies, Inc. (TPIA) Financial Statements (2024 and earlier)

Company Profile

Business Address 480 22ND STREET
HEYBURN, ID 83336
State of Incorp. NV
Fiscal Year End December 31
Industry (SIC) 2833 - Medicinal Chemicals and Botanical Products (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments385,8991,267,51957,359709,164
Cash and cash equivalents385,8991,267,51957,359709,164
Receivables    1,000
Prepaid expense    7,606
Disposal group, including discontinued operation   34,806946,715
Other current assets   48,09650,100
Other undisclosed current assets   315,194(500,000)
Total current assets:385,8991,267,519455,4551,214,585
Noncurrent Assets
Property, plant and equipment1,4962,497 548
Total noncurrent assets:1,4962,497 548
TOTAL ASSETS:387,3951,270,016455,4551,215,133
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:335,590171,0311,14955,967
Accrued liabilities  10,3391,14955,967
Other undisclosed accounts payable and accrued liabilities335,590160,692  
Debt140,923   
Due to related parties 125,000  
Other liabilities    507,263
Other undisclosed current liabilities288,00010,339  
Total current liabilities:764,513306,3701,149563,230
Noncurrent Liabilities
Long-term debt and lease obligation 514,230   
Long-term debt, excluding current maturities 514,230   
Liabilities, other than long-term debt  500,000  
Due to related parties 500,000  
Other undisclosed noncurrent liabilities  123,625  
Total noncurrent liabilities: 514,230623,625  
Total liabilities:1,278,743929,9951,149563,230
Equity
Equity, attributable to parent(891,348)340,021454,306651,903
Common stock14,85713,96612,92512,425
Additional paid in capital6,873,4293,175,95970,35426,246
Retained earnings (accumulated deficit)(7,779,634)(2,849,904)371,027613,232
Total equity:(891,348)340,021454,306651,903
TOTAL LIABILITIES AND EQUITY:387,3951,270,016455,4551,215,133

Income Statement (P&L) (USD)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating expenses(1,736,336)(2,669,109) (251,718)
Operating loss:(1,736,336)(2,669,109) (251,718)
Nonoperating expense(875,533)(151,621) (1,504)
Investment income, nonoperating    16,253
Other nonoperating income    22,251
Interest and debt expense(868,330)(143,057) (8)
Loss from continuing operations before equity method investments, income taxes:(3,480,199)(2,963,787) (253,230)
Other undisclosed income from continuing operations before income taxes868,330143,057 8
Loss from continuing operations:(2,611,869)(2,820,730) (253,222)
Income (loss) before gain (loss) on sale of properties:(2,820,730)84,970(253,222)
Income from discontinued operations   84,970 
Other undisclosed net income (loss)   (327,175)258,025
Net income (loss) available to common stockholders, diluted:(2,611,869)(2,820,730)(242,205)4,803

Comprehensive Income (USD)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Net income (loss):(2,611,869)(2,820,730)(242,205)4,803
Comprehensive income (loss), net of tax, attributable to parent:(2,611,869)(2,820,730)(242,205)4,803

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: